|Bid||6.00 x 3100|
|Ask||6.16 x 800|
|Day's Range||6.03 - 6.32|
|52 Week Range||5.20 - 23.49|
|Beta (5Y Monthly)||1.11|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 09, 2021 - Aug 13, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||23.33|
WOBURN, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a corporate presentation at the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually from September 13 – 15, 2021. Yield10 management will also be available to participate in one-on-one meetings with investors who are registered to attend the conference. Event: H.C.
Viewing insider transactions for Yield10 Bioscience, Inc.'s ( NASDAQ:YTEN ) over the last year, we see that insiders...
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -20.75% and -17.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?